Dandan Tian | Hypertension | Best Researcher Award

Posted on by Pencis

Dr. Dandan Tian | Hypertension | Best Researcher Award

Dr.  Dandan Tian, Henan Provincial People’s Hospital, China

Dr. Dandan Tian is a medical professional at Henan Provincial People’s Hospital in China. With a focus on clinical practice, her expertise spans a variety of medical specialties, particularly in patient care and hospital management. Dr. Tian has made significant contributions to advancing healthcare in the region through her dedication to improving medical services and patient outcomes. She is well-regarded for her professional approach, collaboration with medical teams, and commitment to providing high-quality healthcare. Dr. Tian’s work has also involved research and development aimed at enhancing medical practices and addressing regional healthcare challenges.

Author Profile

Scopus Profile

EARLY ACADEMIC PURSUITS:

Dr. Dandan Tian’s academic journey laid a solid foundation for her distinguished career in hypertension prevention and treatment. After completing her formal medical education, she focused her studies on cardiovascular diseases, particularly hypertension, which has remained a central theme throughout her career. Her commitment to medical research, along with her clinical training, enabled her to understand the complexities of hypertension, and she quickly became passionate about improving treatment protocols and preventative care measures. Early on, her academic curiosity and dedication positioned her to contribute significantly to the growing body of knowledge in her field.

PROFESSIONAL ENDEAVORS:

Dr. Tian currently serves as the Attending Physician in the Hypertension Department of Henan Provincial People’s Hospital. This prestigious role allows her to apply her expertise in diagnosing and treating hypertension while maintaining a hands-on approach with patient care. Beyond her clinical responsibilities, Dr. Tian has taken on significant leadership roles, including Secretary of the Hypertension Prevention and Treatment Center of Henan Province and Secretary of the Hypertension Targeted Center Alliance. Her professional endeavors emphasize collaboration and innovation, as she continues to be a key player in hypertension care across the region.

CONTRIBUTIONS AND RESEARCH FOCUS ON HYPERTENSION:

Dr. Tian’s research focus has been on advancing hypertension prevention, treatment, and management through evidence-based practices. She has made substantial contributions to the field by leading one provincial-level research project and participating in multiple national-level research efforts. These research projects aim to enhance the clinical understanding of hypertension, explore new treatment methods, and implement effective prevention strategies. Her involvement in ministerial and provincial-level research further highlights her commitment to improving public health and addressing hypertension on a broader scale.

IMPACT AND INFLUENCE:

Dr. Tian’s impact extends beyond her clinical and research work. Her leadership in the Hypertension Prevention and Treatment Center of Henan Province and her membership in key medical societies, including the Henan Microcirculation Society, have solidified her influence in the medical community. Additionally, she plays a vital role in shaping healthcare policy and practice, particularly regarding hypertension management and prevention. Dr. Tian was recognized as an exemplary individual in disease prevention and control work by the province in 2021, reflecting the widespread acknowledgment of her contributions to public health.

ACADEMIC CITES AND RECOGNITION:

Dr. Tian’s research has garnered significant academic recognition, with citations from peers and professionals in the field of hypertension and cardiovascular health. Her work on hypertension prevention and treatment protocols has been widely cited, contributing to the academic discourse on hypertension management both within China and internationally. This recognition serves as a testament to the relevance and impact of her research in improving hypertension care practices.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Tian’s legacy is shaped by her pioneering work in hypertension prevention and her dedication to improving patient outcomes. Her research and clinical expertise continue to inspire future generations of healthcare professionals and researchers. Moving forward, Dr. Tian’s contributions are expected to pave the way for further advancements in hypertension management, particularly with her ongoing leadership in various professional committees and research projects. She is committed to continuing her work in hypertension treatment and prevention, and her future contributions are likely to have an enduring impact on the field.

CONCLUSION:

Dr. Dandan Tian’s career reflects a deep commitment to both the clinical and academic sides of hypertension management. Her early academic pursuits, professional endeavors, and continued contributions to research have established her as a leader in the field. Through her work, she has influenced both healthcare policy and patient care practices. With a lasting impact on hypertension prevention, Dr. Tian is poised to continue making significant contributions to the field, solidifying her place as a leading figure in cardiovascular health.

TOP NOTABLE PUBLICATIONS

Article: Effects of obesity on aging brain and cognitive decline: A cohort study from the UK Biobank

Authors: Li, P., Zhu, X., Huang, C., Su, J., Tian, D.

Journal: IBRO Neuroscience Reports

Year: 2025

Article: Joint Exposure to Ambient Air Pollutants, Genetic Risk, and Ischemic Stroke: A Prospective Analysis in UK Biobank

Authors: Li, P., Wang, Y., Tian, D., Su, J., Wang, M.

Journal: Stroke

Year: 2024

Article: Analysis of clinical and biochemical characteristics and left ventricular hypertrophy in patients with indeterminate saline infusion test results

Authors: Qu, H., Zhao, J., Wang, L., Hao, Y., Liu, M.

Journal: Frontiers in Endocrinology

Year: 2024

Article: Causal factors of cardiovascular disease in end-stage renal disease with maintenance hemodialysis: a longitudinal and Mendelian randomization study

Authors: Tian, D., Xu, Y., Wang, Y., Li, P., Li, X.

Journal: Frontiers in Cardiovascular Medicine

Year: 2024

Article: Association Between Plasma Levels of ANGPTL3, 4, 8 and the Most Common Additional Cardiovascular Risk Factors in Patients with Hypertension

Authors: Xu, F., Shen, L., Yang, Y., Cao, X., Huang, G.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2023

Article: Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers

Authors: Xu, F., Tian, D., Shi, X., Sun, K., Chen, Y.

Journal: Pathology and Oncology Research

Year: 2021

Article: Highly sensitive and selective photoelectrochemical sensor for mercury(II) detection based on efficient Bi2MoO6 photoanode decorated with CuS

Authors: Zhang, X., Li, M., He, L., Zhang, J., Liu, M.

Journal: Journal of Alloys and Compounds

Year: 2021

Article: ANGPTL8/betatrophin improves glucose tolerance in older mice and metabolomic analysis reveals its role in insulin resistance in HepG2 cells

Authors: Xu, F., Wang, N., Li, G., Tian, D., Shi, X.

Journal: Diabetes, Metabolic Syndrome and Obesity

Year: 2021

Article: Modeling analysis of the relationship between atherosclerosis and related inflammatory factors

Authors: Li, H., Zhang, P., Yuan, S., Tian, D., Liu, M.

Journal: Saudi Journal of Biological Sciences

Year: 2017

Yasmeen Shamsi | Hypertension | Best Researcher Award

Posted on by Pencis

Yasmeen Shamsi | Hypertension | Best Researcher Award

Prof Yasmeen Shamsi, Jamia Hamdard, India

Yasmeen Shamsi is a prominent researcher in the field of hypertension. She has made significant contributions to our understanding of high blood pressure and its management, which has earned her accolades and recognition in the scientific community. Her research often focuses on the mechanisms underlying hypertension, innovative treatment approaches, and the impact of lifestyle factors on blood pressure regulation.

Profile:
Scopus Profile 
Education:

Yasmeen Shamsi earned her Bachelor of Unani Medicine and Surgery (BUMS) degree from Aligarh Muslim University (AMU), Aligarh, Uttar Pradesh, in 1987. She further pursued advanced studies at Jamia Hamdard in New Delhi, where she completed her Doctor of Medicine (MD) in Moalajat, a branch of Unani medicine, in 2003.

Teaching  Experience:

Dr. Yasmeen Shamsi has a distinguished career in medical education, with significant contributions as a clinical educator and researcher. From 1995 to 2001, she served as a Clinical Registrar at Majeedia Hospital, providing valuable clinical demonstrations to interns and students. She taught Tashreeh-wo-Munafaul Aza (Anatomy & Physiology) to B.U.M.S. first-year students at Jamia Hamdard from July to December 1999. Following this, Dr. Shamsi taught Ummor-e-Tabiya to first-year B.U.M.S. students at Jamia Hamdard from October 2001 to December 2012. Since January 2013, she has been instructing B.U.M.S. second-year students in Ilmul Amraz and B.U.M.S. third-year students, as well as MD (Moalajat) students in Moalajat, continuing her impactful teaching at Jamia Hamdard.

 

Research Experience:

Dr. Yasmeen Shamsi has dedicated over 22 years to clinical research, focusing on a wide array of topics. As a Principal Investigator, she led several significant research projects at HNF, New Delhi. From 2000 to 2002, she examined the effects of Dam-Tab on blood glucose levels in Type-II diabetes mellitus patients and assessed the clinical efficacy of Marham Muhasa in treating acne vulgaris. Her research continued from 2001 to 2005, evaluating the pharmacological effects of Lipotab on lipoprotein levels, and a placebo-controlled, double-blind randomized trial of Qurs-e-Mafasil in rheumatoid arthritis. Between 2003 and 2006, she investigated the impact of Hairi oil and Hairi Plus oil on hair loss. Her subsequent projects, from 2006 to 2009, included a clinical study of Dawa-e-Musakkin for generalized anxiety disorder and an evaluation of Hamdoroid Capsule & Hamdoroid Ointment for hemorrhoids. She also studied the efficacy of a herbal formulation, ‘Diabeat,’ as an adjunct for controlling Type-2 diabetes mellitus from 2007 to 2011.

In her role as a Co-Investigator from 1995 to 1998 at HNF, New Delhi, Dr. Shamsi contributed to studies on Pitkirya Capsules for urticaria treatment, Entropher Tablets for irritable bowel syndrome, and the effectiveness of Qurs Supari Pak Jadeed and Unishaf Pessary for leucorrhoea associated with cervicitis and cervical erosion. Additionally, she co-investigated the clinical trial of Jigreen Syrup and Jigreen Tablet against viral hepatitis.

Top Notable Publications:

  • “Hijāmah (Cupping Therapy) for Pain Management in Patients with Cervical Spondylosis”
    Khan, R., Shamsi, Y., Khan, S.A., Nikhat, S., & Akhtar, W.
    Alternative Therapies in Health and Medicine, 2023, 29(7), pp. 268–271.

  • “Clinical Evaluation of a Topical Unani Pharmacopoeial Formulation Tila-e-Kalf in the Management of Melasma (Kalf): A Randomized Controlled Clinical Trial”
    Salma, Shamsi, Y., Nikhat, S., Akhtar, Md.W., & Ahmad, S.
    Avicenna Journal of Phytomedicine, 2023, 13(3), pp. 255–264.
  • “A Polyherbal Formulation Habb-e-Ustukhuddus Induces Apoptosis and Inhibits Cell Migration in Lung and Breast Cancer Cells without Any Toxicity in Mice”
    Punia, R., Ali, M., Shamsi, Y., & Singh, R.P.
    Asian Pacific Journal of Cancer Prevention, 2023, 24(8), pp. 2713–2727.
  • “Role of AMP-Activated Protein Kinase on Cardio-Metabolic Abnormalities in the Development of Diabetic Cardiomyopathy: A Molecular Landscape”
    Haye, A., Ansari, M.A., Rahman, S.O., Ahmed, D., & Sharma, M.
    European Journal of Pharmacology, 2020, 888, 173376.
  • “Cichorium intybus Attenuates Streptozotocin Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Inflammatory Response in Rats”
    Sharma, M., Afaque, A., Dwivedi, S., Khan, M.I., Ahmed, D.
    Interdisciplinary Toxicology, 2019, 12(3), pp. 111–119.
  • “Clinically Significant Improvement in a Case of Bronchial Asthma with Unani Medicine: A Case Report”
    Shamsi, Y., Khan, R., & Nikhat, S.
    Traditional and Integrative Medicine, 2019, 4(4), pp. 130–136.

  • “Siris (Albizzia lebbeck (L.) Benth.) in View of Unani and Contemporary Pharmacology”
    Khan, S., Shamsi, Y., & Jahangir, U.
    International Journal of Green Pharmacy, 2018, 12(2), pp. S306–S314.